Review
Aug 2026
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.
The preclinical data support the notion that balanced inhibition of GlyT1 may represent a novel mechanistic strategy for the treatment of epilepsy, however, further studies are required to establish its clinical efficacy, optimal dosing, safety profile, and overall therapeutic potential.
Nikola Gapińska, Michał Abram, M. Jakubiec et al.
· Pharmacology and Therapeutic... · 0 citations